NASDAQ: FHTXFoghorn Therapeutics Inc Stock Ownership - Who owns Foghorn Therapeutics?
Insider buying vs selling
Have Foghorn Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Carlos Costa | Chief People Officer | 2024-09-23 | 857 | $3.72 | $3.19kBuy |
| Carlos Costa | Chief People Officer | 2024-09-23 | 857 | $10.17 | $8.72kSell |
| Carlos Costa | Chief People Officer | 2024-09-20 | 35,756 | $10.04 | $358.99kSell |
| Carlos Costa | Chief People Officer | 2024-09-20 | 35,756 | $3.72 | $133.01kBuy |
| Carlos Costa | Chief People Officer | 2024-09-18 | 11,574 | $10.05 | $116.32kSell |
| Carlos Costa | Chief People Officer | 2024-09-18 | 11,574 | $3.72 | $43.06kBuy |
| Carlos Costa | Chief People Officer | 2024-09-17 | 10,272 | $3.72 | $38.21kBuy |
| Carlos Costa | Chief People Officer | 2024-09-17 | 10,272 | $10.04 | $103.13kSell |
| Carlos Costa | Chief People Officer | 2024-09-16 | 400 | $10.00 | $4.00kSell |
| Carlos Costa | Chief People Officer | 2024-09-16 | 400 | $3.72 | $1.49kBuy |
FHTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when FHTX insiders and whales buy or sell their stock.
FHTX Shareholders
What type of owners hold Foghorn Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Flagship Pioneering Inc | 22.74% | 12,674,120 | $68.44M | Institution |
| Fmr LLC | 10.03% | 5,588,874 | $30.18M | Institution |
| Bvf Inc | 9.51% | 5,302,000 | $28.63M | Institution |
| Cigall Kadoch | 6.50% | 3,624,379 | $19.57M | Insider |
| Deerfield Management Company LP Series C | 5.84% | 3,255,514 | $17.58M | Institution |
| Raymond James Financial Inc | 3.98% | 2,218,352 | $11.98M | Institution |
| Blackrock Inc | 3.58% | 1,995,901 | $10.78M | Institution |
| Flagship Ventures Fund V General Partner LLC | 3.32% | 1,851,801 | $10.00M | Insider |
| Vanguard Group Inc | 3.29% | 1,834,628 | $9.91M | Institution |
| Euclidean Capital LLC | 2.82% | 1,573,761 | $8.50M | Institution |
FHTX vs Biotech Stocks
Foghorn Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.